Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Specialised Therapeutics Australia Pty Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013238
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Specialised Therapeutics Australia Pty Ltd (STA) is a biopharmaceutical company that develops and commercializes therapies and technologies for unmet medical needs. The company’s product portfolio includes abraxane, gliolan, oncotype dx, iclusig, oncotype dx prostate and aloxi. Its pipeline products comprise anamorelin and iluvien, among others. STA also offers services such as pharmacovigilance, investigator sponsored clinical trials, warehousing and distribution, commercialisation and marketing and local document filing, regulatory approval and registration. The company’s target therapy areas include oncology, hematology, urology, CNS and endocrinology. It partners international partner companies. The company markets its products across Australia and New Zealand. STA is headquartered in Melbourne, Victoria, Australia.

Specialised Therapeutics Australia Pty Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Specialised Therapeutics Australia Pty Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
Alimera Sciences Enters Into Distribution Agreement With Specialised Therapeutics For Iluvien 12
Ariad Pharma Enters Into Agreement With Specialised Therapeutics To Commercialize Iclusig In Australia 13
Licensing Agreements 14
Puma Biotechnology Enters into Licensing Agreement with Specialised Therapeutics 14
Specialised Therapeutics Asia Enters into Licensing Agreement with Pharma Mar 15
Aeterna Zentaris Enters into Licensing Agreement with Specialised Therapeutics Asia 16
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 17
Mundipharma Enters into Licensing Agreement with Specialized Therapeutics 18
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 19
Helsinn Healthcare Enters Into Licensing Agreement With Specialised Therapeutics Australia For Anamorelin 20
Optimer Pharma Enters Into Licensing Agreement With Specialised Therapeutics For Fidaxomicin 22
Helsinn Enters Into Licensing Agreement With Specialised Therapeutics 23
Specialised Therapeutics Australia Enters Into Licensing Agreement With photonamic For Gliolan 24
Specialised Therapeutics Australia Pty Ltd – Key Competitors 25
Specialised Therapeutics Australia Pty Ltd – Key Employees 26
Specialised Therapeutics Australia Pty Ltd – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Specialised Therapeutics Australia Pty Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
Specialised Therapeutics Australia Pty Ltd, Medical Devices Deals, 2011 to YTD 2017 9
Specialised Therapeutics Australia Pty Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Alimera Sciences Enters Into Distribution Agreement With Specialised Therapeutics For Iluvien 12
Ariad Pharma Enters Into Agreement With Specialised Therapeutics To Commercialize Iclusig In Australia 13
Puma Biotechnology Enters into Licensing Agreement with Specialised Therapeutics 14
Specialised Therapeutics Asia Enters into Licensing Agreement with Pharma Mar 15
Aeterna Zentaris Enters into Licensing Agreement with Specialised Therapeutics Asia 16
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 17
Mundipharma Enters into Licensing Agreement with Specialized Therapeutics 18
Specialised Therapeutics Enters into Licensing Agreement with Pharma Mar 19
Helsinn Healthcare Enters Into Licensing Agreement With Specialised Therapeutics Australia For Anamorelin 20
Optimer Pharma Enters Into Licensing Agreement With Specialised Therapeutics For Fidaxomicin 22
Helsinn Enters Into Licensing Agreement With Specialised Therapeutics 23
Specialised Therapeutics Australia Enters Into Licensing Agreement With photonamic For Gliolan 24
Specialised Therapeutics Australia Pty Ltd, Key Competitors 25
Specialised Therapeutics Australia Pty Ltd, Key Employees 26
Specialised Therapeutics Australia Pty Ltd, Subsidiaries 27

★海外企業調査レポート[Specialised Therapeutics Australia Pty Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Proximus plc:企業の戦略・SWOT・財務分析
    Proximus plc - Strategy, SWOT and Corporate Finance Report Summary Proximus plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • University of Wisconsin Madison-製薬・医療分野:企業M&A・提携分析
    Summary University of Wisconsin Madison (UW-Madison), a subsidiary of University of Wisconsin System is an educational and research institution that provides undergraduate and postgraduate courses. The institution offers courses in various fields such as agricultural and life sciences, arts, busines …
  • E-CO Energi Holding AS:企業の戦略的SWOT分析
    E-CO Energi Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • CJ Corp (001040):企業の財務・戦略的SWOT分析
    CJ Corp (001040) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • MallInckrodt Plc (MNK)-医療機器分野:企業M&A・提携分析
    Summary Mallinckrodt Plc (Mallinckrodt) is a healthcare products provider that offers generics and active pharmaceutical ingredients. The company offers generic products which include addiction treatment products, compounding powders, unit dose products and resource tool kits. Its active pharmaceuti …
  • Quadrise Fuels International Plc (QFI):企業の財務・戦略的SWOT分析
    Quadrise Fuels International Plc (QFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Tenaga Nasional Berhad (TENAGA)-エネルギー分野:企業M&A・提携分析
    Summary Tenaga Nasional Berhad (TNB) is an electricity utility that generates, transmits, distributes and supplies power. It develops, operates and maintains a portfolio of power generating units. The company produces electricity from crude oil, natural gas, hydro, coal and gas sources. TNB also sup …
  • Intarcia Therapeutics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Intarcia Therapeutics Inc (Intarcia), formerly BioMedicines Inc, is a biopharmaceutical company that focuses on the development of therapies through its proprietary Medici Drug Delivery System, a subcutaneous delivery system to treat chronic conditions. The company’s product candidate includ …
  • Whataburger Restaurants LP:戦略・SWOT・企業財務分析
    Whataburger Restaurants LP - Strategy, SWOT and Corporate Finance Report Summary Whataburger Restaurants LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Mitsubishi Tanabe Pharma Corporation:企業の戦略・SWOT・財務分析
    Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report Summary Mitsubishi Tanabe Pharma Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Prudential Financial, Inc.:企業のM&A・事業提携・投資動向
    Prudential Financial, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Prudential Financial, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • G4S Plc (GFS):企業の財務・戦略的SWOT分析
    G4S Plc (GFS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Siemens Ltd (SIEMENS):企業の財務・戦略的SWOT分析
    Siemens Ltd (SIEMENS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Mallinckrodt LLC:医療機器:M&Aディール及び事業提携情報
    Summary Mallinckrodt LLC (Mallinckrodt), formerly Therakos Inc, a subsidiary of Mallinckrodt Plc, is a provider of autologous immune cell therapy through extracorporeal photopheresis. The company provides Therakos Cellex Photopheresis system, which is indicated for use in ultraviolet-A irradiation i …
  • Adapt Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Adapt Pharma Ltd (Adapt Pharma) is a drug discovery and development company that manufactures and distributes prescription medicines. The company’s product Narcan (naloxone hydrochloride) nasal spray is an opioid antagonist that is indicated for the emergency treatment of opioid overdose as …
  • Smith & Nephew Plc (SN.):医療機器:M&Aディール及び事業提携情報
    Summary Smith & Nephew Plc (Smith & Nephew) is a medical technology company that develops, manufactures and markets medical devices for use in orthopaedic reconstruction and trauma, sports medicines and advanced wound management. The company offers its products in various categories including Sports …
  • Banco de Sabadell SA:企業のM&A・事業提携・投資動向
    Banco de Sabadell SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Banco de Sabadell SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Husqvarna AB (HUSQ B):企業の財務・戦略的SWOT分析
    Summary Husqvarna AB (Husqvarna) is an industrial equipment company. The company produces outdoor power products for forestry, gardening and construction. It offers wheeled products, electric products. Husqvarna also provides handheld products, watering and hand tools, accessories, and construction …
  • King Country Energy Limited:企業の戦略的SWOT分析
    King Country Energy Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Xintela AB (XINT):企業の財務・戦略的SWOT分析
    Summary Xintela AB (Xintela) is a biomedical company that develops treatment for cartilage damage and brain tumors. The company’s technology includes Xinmark, a patented marker technology developed to identify and select certain types of tumor cells, which can develop into cartilage cells. It also p …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆